104 related articles for article (PubMed ID: 452871)
1. The treatment of postmenopausal syndrome by monthly oral doses of quinestrol.
Jaschevatzky OE; Anderman S; Shalit A; Kampf D; Grünstein S
Acta Obstet Gynecol Scand; 1979; 58(2):175-8. PubMed ID: 452871
[TBL] [Abstract][Full Text] [Related]
2. Effect of quinestrol on plasma and urinary gonadotropins of postmenopausal women.
Ricciardi I; Bruni G; Imparato E; Marino L; Pesando P
Horm Metab Res; 1975 Jul; 7(4):323-6. PubMed ID: 1150131
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies on low dose estradiol 17 beta administered orally to postmenopausal women.
Sipinen S; Lähteenmäki P; Luukkainen T
Acta Obstet Gynecol Scand; 1980; 59(2):149-53. PubMed ID: 6773291
[TBL] [Abstract][Full Text] [Related]
4. Pill-a-month as an oral contraceptive.
Hefnawi F; Hassanein M; Younis N
Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
[TBL] [Abstract][Full Text] [Related]
5. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
Robyn C; Vekemans M
Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
[TBL] [Abstract][Full Text] [Related]
6. Replacement estrogen therapy for menopausal vasomotor flushes. Comparison of quinestrol and conjugated estrogens.
Baumgardner SB; Condrea H; Daane TA; Dorsey JH; Jurow HN; Shively JP; Wachsman M; Wharton LR; Zibel MJ
Obstet Gynecol; 1978 Apr; 51(4):445-52. PubMed ID: 208034
[TBL] [Abstract][Full Text] [Related]
7. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
Furuhjelm M; Carlström K
Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hepatic impact of oral and vaginal administration of ethinyl estradiol.
Goebelsmann U; Mashchak CA; Mishell DR
Am J Obstet Gynecol; 1985 Apr; 151(7):868-77. PubMed ID: 3920910
[TBL] [Abstract][Full Text] [Related]
9. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
10. Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: correlations with gonadotropin levels.
Schiff I; Tulchinsky D; Ryan KJ; Kadner S; Levitz M
Am J Obstet Gynecol; 1980 Dec; 138(8):1137-41. PubMed ID: 6778214
[TBL] [Abstract][Full Text] [Related]
11. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
12. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
[TBL] [Abstract][Full Text] [Related]
13. [Changes in carbohydrate tolerance in the puerperium by inhibition of lactation with bromocriptine and quinestrol (author's transl)].
Peters FD; Roemer VM
Arch Gynakol; 1977 Sep; 223(2):93-7. PubMed ID: 578680
[TBL] [Abstract][Full Text] [Related]
14. Contraceptive effect and tolerance of monthly oral doses of quinestrol (author's transl).
Jaschevatzky OE; Shalit A; Grunstein S
Acta Eur Fertil; 1972 Sep; 3(3):269-80. PubMed ID: 4679562
[TBL] [Abstract][Full Text] [Related]
15. Control of fertility with oral medication.
Diddle AW; Watts GF; Gardner WH; Williamson PJ
West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
18. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
19. Fertility following termination of the once-a-month oral contraceptive.
Maqueo-Topete M; Mischler TW
Contraception; 1974 Sep; 10(3):299-304. PubMed ID: 4442272
[TBL] [Abstract][Full Text] [Related]
20. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
Chakravarti S; Collins WP; Thom MH; Studd JW
Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
